Rivaroxaban, a cost-effective alternative for SVT?
Crossref DOI link: https://doi.org/10.1038/nrcardio.2017.27
Published Online: 2017-03-02
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fernández-Ruiz, Irene
Text and Data Mining valid from 2017-03-02
Article History
First Online: 2 March 2017